Compound Detail
CHEMBL5758218
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@H]1OC(=O)[C@]2(C(N)=O)CC(F)(F)[C@@H](C)[C@H](/C=C/c3ccc(-c4cccc5c4OC(F)(F)O5)cn3)[C@H]12
Basic Information
| ChEMBL ID | CHEMBL5758218 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RNCJCFSBCWLWAT-QNGRFZOLSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
506.4
MW (Da)
4.41
ALogP
6
HBA
1
HBD
100.7
PSA (Ų)
0.37
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.81
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.81 | 4.81 | 15400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 15400.0 | nM | 4.81 | MK-499 Filter Binding Assay: Drug cardiac arrhythmia is an important safety conc... | - |
Data from ChEMBL 36 via Core Engine